Re: I have a growing concern....
|
5
|
Resverlogix Corp.
|
Feb 28, 2020 12:22PM
|
Re: I have a growing concern....
|
1
|
Resverlogix Corp.
|
Feb 28, 2020 01:44PM
|
Re: H1 2020 Potential Events
|
3
|
Resverlogix Corp.
|
Mar 01, 2020 10:11PM
|
BRD2 involvement in Covid19
|
14
|
Resverlogix Corp.
|
Mar 18, 2020 12:03PM
|
Re: BRD2 involvement in Covid19
|
4
|
Resverlogix Corp.
|
Mar 18, 2020 12:14PM
|
Re: BRD2 involvement in Covid19
|
6
|
Resverlogix Corp.
|
Mar 18, 2020 12:28PM
|
Re: BRD2 involvement in Covid19
|
3
|
Resverlogix Corp.
|
Mar 18, 2020 12:40PM
|
Re: BRD2 involvement in Covid19
|
2
|
Resverlogix Corp.
|
Mar 18, 2020 01:03PM
|
Re: BRD2 involvement in Covid19
|
3
|
Resverlogix Corp.
|
Mar 18, 2020 01:10PM
|
Re: Dear Dr. Shokat -- Received a reply !!
|
3
|
Resverlogix Corp.
|
Mar 18, 2020 03:49PM
|
Re: Dear Dr. Shokat -- Received a reply !!
|
7
|
Resverlogix Corp.
|
Mar 18, 2020 03:54PM
|
Re: Dear Dr. Shokat -- Received a reply !!
|
7
|
Resverlogix Corp.
|
Mar 18, 2020 04:07PM
|
Re: BD2 specific inhibitors mentioned in Science
|
4
|
Resverlogix Corp.
|
Mar 22, 2020 01:46PM
|
Re: Epigenetics and Coronavirus
|
5
|
Resverlogix Corp.
|
Mar 23, 2020 04:22PM
|
Re: Epigenetics and Coronavirus
|
8
|
Resverlogix Corp.
|
Mar 23, 2020 05:14PM
|
Re: Angiotensin and Coronavirus
|
3
|
Resverlogix Corp.
|
Mar 23, 2020 10:20PM
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
8
|
Resverlogix Corp.
|
Mar 24, 2020 02:05PM
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 24, 2020 03:54PM
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
2
|
Resverlogix Corp.
|
Mar 24, 2020 04:20PM
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
5
|
Resverlogix Corp.
|
Mar 24, 2020 04:33PM
|